Oruka Therapeutics Inc. (ORKA)
NASDAQ: ORKA
· Real-Time Price · USD
14.29
-0.27 (-1.85%)
At close: Aug 20, 2025, 10:03 AM
Oruka Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.57M | -21M | -25.78M | -28.62M | -2.68M | -7.08M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Depreciation & Amortization | 19K | 16K | 16K | n/a | 12K | n/a | 28K | 28K | 27K | 19K | 17K |
Stock-Based Compensation | 5.08M | n/a | n/a | n/a | n/a | 85K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.71M | -3.12M | 2.14M | 5.93M | -80K | 987K | -1.12M | 588K | 777K | 357K | -1.34M |
Other Non-Cash Items | -1.38M | 3.15M | 2.97M | -13.58M | 112K | 1K | 169K | 119K | 104K | 133K | 141K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.29M | -3.03M | 3.98M | 7.34M | -80K | 6.82M | -1.22M | 582K | -289K | 962K | -1.28M |
Operating Cash Flow | -23.14M | -20.87M | -18.82M | -34.86M | -2.63M | -168K | -4.3M | -4.95M | -4.87M | -3.72M | -5.22M |
Capital Expenditures | -34K | -13K | -18K | -171K | n/a | n/a | -2K | -7K | -14K | -16K | -6K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -108M | -44.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 112.89M | 87.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -329.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 4.86M | 42.87M | -329.96M | -171K | n/a | n/a | -2K | -7K | -14K | -16K | -6K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 24.98M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -29.92M | 29.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 109K | n/a | -526K | 450.05M | 14K | 27.91M | n/a | n/a | n/a | n/a | 23.09M |
Net Cash Flow | -18.18M | 22M | -349.3M | 377.59M | -2.62M | 27.74M | -4.3M | -4.95M | -4.88M | -3.74M | 17.86M |
Free Cash Flow | -23.18M | -20.88M | -18.84M | -35.03M | -2.63M | -168K | -4.3M | -4.95M | -4.88M | -3.74M | -5.23M |